Markets:

Overview

News

Currencies

International

Treasuries

Abeona Therapeutics Inc. - Common Stock (NQ:ABEO)

5.080 -0.280 (-5.22%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 15, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abeona Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

FDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares Sink ↗

April 23, 2024

Abeona Therapeutics' pz-cel gets the FDA's Complete Response Letter and Abeona's plans for fulfilling Chemistry Manufacturing and Controls requirements.

Via Benzinga

Why Is Greenwave Technology Solutions (GWAV) Stock Down 47% Today? ↗

April 23, 2024

Greenwave Technology Solutions stock is down on Tuesday as GWAV investors react to a registered direct offering and private placement.

Via InvestorPlace

Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today? ↗

April 23, 2024

Abeona Therapeutics stock is falling on Tuesday after the FDA sent it a CRL for more CMC data before it would approve Pz-cel.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 23, 2024

Via Benzinga

Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket ↗

April 23, 2024

Via Benzinga

Recap: Abeona Therapeutics Q3 Earnings ↗

November 13, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 23, 2024

We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Tuesday morning!

Via InvestorPlace

Calix Reports Mixed Results, Joins Cadence Design Systems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

April 23, 2024

Via Benzinga

Abeona Therapeutics Provides Regulatory Update on Pz-cel

April 22, 2024

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 01, 2024

From Abeona Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 19, 2024

Via Benzinga

ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q4 2023 ↗

March 19, 2024

ABEO stock results show that Abeona Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections

March 18, 2024

- FDA completed Pre-License Inspection of Abeona’s Cleveland manufacturing facility, as well as inspection of clinical trial sites for pz-cel pivotal Phase 3 VIITAL™ study -

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 05, 2024

From Abeona Therapeutics Inc.

Via GlobeNewswire

Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying ↗

February 08, 2024

The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 07, 2024

Via Benzinga

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 01, 2024

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)

February 01, 2024

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics Announces $50 Million Credit Facility

January 08, 2024

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 15, 2023

From Abeona Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 27, 2023

Via Benzinga

Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA)

November 27, 2023

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments

November 13, 2023

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 01, 2023

From Abeona Therapeutics Inc.

Via GlobeNewswire

The 7 Most Undervalued Penny Stocks to Buy in October 2023 ↗

October 06, 2023

Undervalued penny stocks offer tremendous return for investors with an appetite for risk but these shares are relatively safe as well.

Via InvestorPlace

Abeona Therapeutics Submits Biologics License Application to U.S. FDA Seeking Priority Review and Approval of EB-101 for the Treatment of Patients with Recessive Dystrophic Epidermolysis Bullosa

September 26, 2023

From Abeona Therapeutics Inc.

Via GlobeNewswire

3 Biotech Blockbusters to Turn $5,000 Into $50,000 ↗

September 12, 2023

These transformative early-stage biotech stocks can deliver triple-digit upside if their key milestones are achieved on time.

Via InvestorPlace

Abeona Therapeutics Appoints Madhav Vasanthavada, Ph.D., M.B.A. as Chief Commercial Officer

September 12, 2023

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics Announces Participation in Upcoming Investor Conferences

September 07, 2023

From Abeona Therapeutics Inc.

Via GlobeNewswire

Abeona Therapeutics Announces Positive Pre-BLA Meeting with FDA for EB-101 and Plans for BLA Submission

August 30, 2023

From Abeona Therapeutics Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Abeona Therapeutics Inc. - Common Stock (NQ:ABEO)

All News about Abeona Therapeutics Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today